Temocillin use in England: Clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 11, 2011, Pages 2628-2631

  Balakrishnan, Indran ^a   Awad El Kariem, F Mustafa ^b   Aali, Adnan ^c   Kumari, Prasanna ^d   Mulla, Rohinton ^e   Tan, Benny ^f   Brudney, Daniel ^a   Ladenheim, David ^b   Ghazy, Anan ^c   Khan, Imran ^e   Virgincar, Nilangi ^f   Iyer, Shabnam ^f   Carryn, Stephane ^g   Van de Velde, Sebastien ^g  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b MOUNT VERNON CANCER CENTRE   (United Kingdom)

^c EALING HOSPITAL NHS TRUST   (United Kingdom)

^d Hillingdon Hospital NHS Trust   (United Kingdom)

^e BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

^f ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^g Eumedica SA   (Belgium)

Author keywords

Clostridium difficile; Dosage; Regimen

Indexed keywords

BETA LACTAMASE AMPC; TEMOCILLIN;

ARTICLE; BLOODSTREAM INFECTION; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; ENTEROBACTERIACEAE INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; RETROSPECTIVE STUDY; UNITED KINGDOM; URINARY TRACT INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CLOSTRIDIUM DIFFICILE; ENGLAND; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; SEPSIS; URINARY TRACT INFECTIONS;

EID: 80054686935     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr317     Document Type: Article

References (10)

1. Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol 2010; 300: 371-9.
2. Livermore DM, Warner M, Mushtaq S et al. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011; 37: 415-9.
3. Slama TG. Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use. Crit Care 2008; 12: 233.
4. Livermore DM, Tulkens PM. Temocillin revived. J Antimicrob Chemother 2009; 63: 243-5.
5. Gobernado M, Canton E. Comparative in vitro activity of temocillin. Drugs 1985; 29 Suppl 5: 24-31.
6. Livermore DM, Woodford N. Laboratory detection and reporting of bacteria with extended spectrum β-lactamases. Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency, London, 2004.
7. Gupta ND, Smith RE, Balakrishnan I. Clinical efficacy of temocillin. J Antimicrob Chemother 2009; 64: 431-3.
8. De Jongh R, Hens R, Basma V et al. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008; 61: 382-8.
9. Hampel B, Feike M, Koeppe P et al. Pharmacokinetics of temocillin in volunteers. Drugs 1985; 29 Suppl 5: 99-102.
10. Van der Waaij D. Selective decontamination of the digestive tract with oral aztreonam and temocillin. Rev Infect Dis 1985; 7 Suppl 4: S628-34.